Rapicure M Syrup
By Rapicure M
Rx
60ml Syrup in a Bottle

Composition
Mefenamic Acid(100mg/5ml) + Paracetamol(250mg/5ml)

Manufacturer - Haustus Biotech Pvt Ltd
44-45 Industrial Area , Tahliwal Distt. UNA Himachal Pradesh (India)

Expires on or after
July, 2025

liver
It is important to be cautious when using Rapicure M Syrup in patients with liver disease, as dose adjustment may be necessary. It is advised to consult a doctor before using this syrup. However, Rapicure M Syrup is not recommended for patients with severe liver disease or active liver disease.

kidney
Rapicure M Syrup should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Avoid using Rapicure M Syrup in cases of severe kidney disease. Consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Rapicure M Syrup.

driving
Rapicure M Syrup may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Rapicure M Syrup may be risky during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor for a careful evaluation of benefits and risks before using this medication.

breastfeeding
Rapicure M Syrup is considered safe to use while breastfeeding. Research indicates that the medication does not transfer in significant quantities to breastmilk and poses no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹46.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024